GSK joins with US biotech to toughen up cell therapies for solid tumoursGlaxoSmithKline has announced a five-year collaboration with San Francisco biotech Lyell Immunopharma, to strengthen therapeutic T-cells before they Share XGSK joins with US biotech to toughen up cell therapies for solid tumourshttps://pharmaphorum.com/news/gsk-joins-with-us-biotech-to-toughen-up-cell-therapies-for-solid-tumours/
